Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma
May 26, 2023 17:30 ET
|
Iovance Biotherapeutics, Inc.
Priority Review Granted withPrescription Drug User Fee Act (PDUFA) Action Date of November 25, 2023 First Potential Approval of an Individualized, One-Time Cell Therapy for Patients with Advanced...
StoneCo Announces Mateus Scherer as new CFO, Change in Role of our President Augusto Lins and Split of Board Committees
May 26, 2023 17:30 ET
|
StoneCo Ltd.
GEORGETOWN, Cayman Islands, May 26, 2023 (GLOBE NEWSWIRE) -- StoneCo Ltd. (Nasdaq: STNE; B3: STOC31) (“Stone” or the “Company”), announced key management changes today, including the promotion of...
Senior Connect Acquisition Corp. I Announces it Will Redeem its Public Shares and Will Not Consummate an Initial Business Combination
May 26, 2023 17:30 ET
|
Senior Connect Acquisition Corp. I
Scottsdale, AZ, May 26, 2023 (GLOBE NEWSWIRE) -- Senior Connect Acquisition Corp. I (the “Company”) (Nasdaq: SNRH), announced today that, the board of directors of the Company has unanimously voted...
Logistics Innovation Technologies Corp. Announces Redemption of Shares
May 26, 2023 17:19 ET
|
LOGISTICS INNOVATION TECHNOLOGIES CORP
Atlanta, GA, May 26, 2023 (GLOBE NEWSWIRE) -- Logistics Innovation Technologies Corp. (NASDAQ: LITT) (the “Company”) today announced that its board of directors (the “Board”) has determined to...
Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
May 26, 2023 17:10 ET
|
Molecular Templates, Inc.
AUSTIN, Texas, May 26, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and...
Aetherium Acquisition Corp. Receives Notice Regarding Late Form 10-Q Filing From The Nasdaq Stock Market LLC
May 26, 2023 16:35 ET
|
Aetherium Acquisition Corp.
GREENWICH, CT, May 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Aetherium Acquisition Corp. (NASDAQ: GMFIU, the “Company”) announced today that it received a notice (the "Notice") on May 23,...
Smart Powerr Corp. Receives Notice of Filing Delinquency From Nasdaq
May 26, 2023 16:30 ET
|
SMART POWERR CORP.
XI’AN, China, May 26, 2023 (GLOBE NEWSWIRE) -- Smart Powerr Corp. (NASDAQ: CREG) (“CREG” or the “Company”), an industrial waste-to-energy solution provider in China, announced today that it received...
BullFrog AI Files Quarterly Report on Form 10-Q
May 26, 2023 16:30 ET
|
BullFrog AI Holdings, Inc.
GAITHERSBURG, Md., May 26, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or the "Company"), a digital technology company using machine learning to usher in...
Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering
May 26, 2023 16:05 ET
|
Biodexa Pharmaceuticals PLC
26 May 2023 Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX), a...
Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure
May 26, 2023 16:05 ET
|
Lexicon Pharmaceuticals, Inc.
INPEFA granted broad label across full range of left ventricular ejection fraction, including HFpEF and HFrEF, and for patients with or without diabetes INPEFA reduced the risk of total occurrence...